"Rx-to-OTC Switching and the Continuing Importance of Emerging Pharma Markets Will Drive OTC Sales Growth from 2009 Onwards," Announced Visiongain Brand New Report
OTC pharma is influenced by changes in consumer spending - but significant commercial opportunities for OTC switching will drive market expansion worldwide – Visiongain new report explains.
London, United Kingdom, May 24, 2009 --(PR.com)-- Article Source: http://www.visiongain.com/Report.aspx?rid=389
General economic trends worldwide will affect the over-the-counter (OTC) pharma market from 2009 onwards, with both market restraints and opportunities present. In this new report - The Global OTC Pharmaceutical Market 2009-2024 – visiongain notes that Rx-to-OTC switching and the continuing importance of emerging pharma markets will drive OTC sales growth from 2009 onwards. Visiongain forecasts reveal that the OTC pharma market will grow significantly next decade. This report explains where future OTC switching will occur, providing you with the information that client need to understand the current OTC market and its future prospects. The potential of this market remains significant, despite general economic uncertainty, visiongain asserts.
The Global OTC Pharmaceutical Market 2009-2024 examines all the major categories of OTC pharmaceuticals, including:
• Analgesics – for internal and external uses
• Cough, cold and allergy preparations
• Dermatology - including antifungal agents and hair-loss treatments
• Gastrointestinal drugs - including those for acid-related disorders, laxatives and anti-diarrhoea preparations
• Anti-obesity treatments
• Smoking cessation aids
• Others – including contraceptives, statins and erectile dysfunction areas.
Comprehensive analysis of the OTC market area
The Global OTC Pharmaceutical Market 2009-2024 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. This report provides detailed sales forecasts, discussions of pipeline developments and analysis of commercial drivers and restraints, including a SWOT analysis. There are over 100 tables and figures included. The result is a comprehensive market- and industry-centred report, with detailed analyses and informed opinion to aid your work.
Why people should read The Global OTC Pharmaceutical Market 2009-2024
• Receiving a comprehensive appraisal of the OTC pharmaceutical market in 2008, including sales revenues and market shares for OTC categories, the top 10 companies and the leading OTC brands
• Receiving sales forecasts and discussions covering the period 2009 to 2024, including the global OTC market, leading OTC brand forecasts, top OTC manufacturer forecasts and therapeutic category forecasts
• Viewing sales forecasts for leading national OTC markets worldwide
• Receiving coverage of OTC switching from 2009 onwards, with important developments that you cannot ignore
• Viewing strengths, weaknesses, opportunities and threats facing the industry, with an emphasis on commercial drivers and restraints.
Visiongain ltd.
4th Floor,
BSG House,
226 236 City Road,
London
EC1V 2QY
United Kingdom
Telephone: +44 (0) 20 7336 6100
Fax: +44 (0) 20 7549 9930
info@visiongainglobal.com
Or Visit at: http://www.visiongain.com/Report.aspx?rid=389
Or http://www.visiongain.com
Or
Contact Person
Suvitha Damodaran
suvitha.damodaran@visiongainglobal.com
Direct Line: +44 (0)20 7549 9946
+44 (0)20 7336 6100
###
General economic trends worldwide will affect the over-the-counter (OTC) pharma market from 2009 onwards, with both market restraints and opportunities present. In this new report - The Global OTC Pharmaceutical Market 2009-2024 – visiongain notes that Rx-to-OTC switching and the continuing importance of emerging pharma markets will drive OTC sales growth from 2009 onwards. Visiongain forecasts reveal that the OTC pharma market will grow significantly next decade. This report explains where future OTC switching will occur, providing you with the information that client need to understand the current OTC market and its future prospects. The potential of this market remains significant, despite general economic uncertainty, visiongain asserts.
The Global OTC Pharmaceutical Market 2009-2024 examines all the major categories of OTC pharmaceuticals, including:
• Analgesics – for internal and external uses
• Cough, cold and allergy preparations
• Dermatology - including antifungal agents and hair-loss treatments
• Gastrointestinal drugs - including those for acid-related disorders, laxatives and anti-diarrhoea preparations
• Anti-obesity treatments
• Smoking cessation aids
• Others – including contraceptives, statins and erectile dysfunction areas.
Comprehensive analysis of the OTC market area
The Global OTC Pharmaceutical Market 2009-2024 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. This report provides detailed sales forecasts, discussions of pipeline developments and analysis of commercial drivers and restraints, including a SWOT analysis. There are over 100 tables and figures included. The result is a comprehensive market- and industry-centred report, with detailed analyses and informed opinion to aid your work.
Why people should read The Global OTC Pharmaceutical Market 2009-2024
• Receiving a comprehensive appraisal of the OTC pharmaceutical market in 2008, including sales revenues and market shares for OTC categories, the top 10 companies and the leading OTC brands
• Receiving sales forecasts and discussions covering the period 2009 to 2024, including the global OTC market, leading OTC brand forecasts, top OTC manufacturer forecasts and therapeutic category forecasts
• Viewing sales forecasts for leading national OTC markets worldwide
• Receiving coverage of OTC switching from 2009 onwards, with important developments that you cannot ignore
• Viewing strengths, weaknesses, opportunities and threats facing the industry, with an emphasis on commercial drivers and restraints.
Visiongain ltd.
4th Floor,
BSG House,
226 236 City Road,
London
EC1V 2QY
United Kingdom
Telephone: +44 (0) 20 7336 6100
Fax: +44 (0) 20 7549 9930
info@visiongainglobal.com
Or Visit at: http://www.visiongain.com/Report.aspx?rid=389
Or http://www.visiongain.com
Or
Contact Person
Suvitha Damodaran
suvitha.damodaran@visiongainglobal.com
Direct Line: +44 (0)20 7549 9946
+44 (0)20 7336 6100
###
Contact
Visiongain Ltd.
Suvitha Damodaran
+44 (0) 20 7336 6100
http://www.visiongain.com
4th Floor,
BSG House,
226 236 City Road,
London
EC1V 2QY
United Kingdom
Contact
Suvitha Damodaran
+44 (0) 20 7336 6100
http://www.visiongain.com
4th Floor,
BSG House,
226 236 City Road,
London
EC1V 2QY
United Kingdom
Categories